BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 115 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $1,256,000 | -70.3% | 22,197 | -70.1% | 0.00% | -50.0% |
Q4 2019 | $4,227,000 | -1.3% | 74,228 | -7.3% | 0.00% | 0.0% |
Q3 2019 | $4,284,000 | -37.1% | 80,049 | -29.8% | 0.00% | -33.3% |
Q2 2019 | $6,809,000 | +52.4% | 114,034 | +59.1% | 0.01% | +50.0% |
Q1 2019 | $4,468,000 | +12.0% | 71,692 | +8.8% | 0.00% | 0.0% |
Q4 2018 | $3,991,000 | -2.3% | 65,864 | -5.7% | 0.00% | 0.0% |
Q3 2018 | $4,086,000 | +36.9% | 69,865 | +5.0% | 0.00% | +33.3% |
Q2 2018 | $2,984,000 | +2.3% | 66,512 | +1.1% | 0.00% | 0.0% |
Q1 2018 | $2,918,000 | +0.8% | 65,819 | -1.5% | 0.00% | +50.0% |
Q4 2017 | $2,895,000 | -26.7% | 66,804 | -21.3% | 0.00% | -33.3% |
Q3 2017 | $3,950,000 | -5.7% | 84,901 | +0.3% | 0.00% | -25.0% |
Q2 2017 | $4,190,000 | +14.8% | 84,621 | +27.1% | 0.00% | 0.0% |
Q1 2017 | $3,649,000 | +11.2% | 66,595 | +13.0% | 0.00% | +33.3% |
Q4 2016 | $3,282,000 | +8.1% | 58,919 | -11.4% | 0.00% | 0.0% |
Q3 2016 | $3,037,000 | +6.9% | 66,495 | -6.5% | 0.00% | 0.0% |
Q2 2016 | $2,842,000 | +10.5% | 71,149 | -3.7% | 0.00% | 0.0% |
Q1 2016 | $2,573,000 | -68.3% | 73,891 | -60.8% | 0.00% | -66.7% |
Q4 2015 | $8,108,000 | -1.3% | 188,681 | -0.0% | 0.01% | -10.0% |
Q3 2015 | $8,216,000 | +75.3% | 188,708 | +107.7% | 0.01% | +100.0% |
Q2 2015 | $4,688,000 | +39.9% | 90,848 | +6.2% | 0.01% | +25.0% |
Q1 2015 | $3,350,000 | +59.8% | 85,570 | +57.7% | 0.00% | +100.0% |
Q4 2014 | $2,096,000 | +201.6% | 54,277 | +175.5% | 0.00% | +100.0% |
Q3 2014 | $695,000 | – | 19,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|